OTCBB:RGRX

Regenerx Biopharmaceuticals Stock Forecast

etoro logo Buy RGRX
*Your capital is at risk
$0.0006
+0 (+0%)
At Close: Jun 11, 2026
Add RGRX to Watchlist?
Some Reasons Why To Add RGRX:
  • +200.0% price growth over the last year
  • High gross margin of 100.0%
  • Strong return on equity of 60.9%

RGRX Performance

FAQ

What is the symbol for Regenerx Biopharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Regenerx Biopharmaceuticals Inc is RGRX and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell Regenerx Biopharmaceuticals Inc Stock?
Regenerx Biopharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Regenerx Biopharmaceuticals Inc Stock?
Regenerx Biopharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Regenerx Biopharmaceuticals Inc Stock.

What's the current price of Regenerx Biopharmaceuticals Inc Stock?
As of the end of day on the Jun 11, 2026, the price of an Regenerx Biopharmaceuticals Inc (RGRX) share was $0.0006.

What is the 52-week high and low for Regenerx Biopharmaceuticals Inc Stock?
The 52-week high for Regenerx Biopharmaceuticals Inc Stock is $0.163 and the 52-week low is $0.0002.

What is the market capitalization of Regenerx Biopharmaceuticals Inc Stock?
As of the Jun 11, 2026, the market capitalization of Regenerx Biopharmaceuticals Inc is 898.
Click to get the best stock tips daily for free!
ABOUT REGENERX BIOPHARMACEUTICALS INC
Regenerx Biopharmaceuticals
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous sys...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.01% Jun 05
TPR
$140.47
3.50% Jun 04
GLBE
$31.61
5.09% May 05
FIZZ
$34.11
8.36% May 01
W
WCLD
$27.34
12.18% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE